Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas

BACKGROUND: KIT is a proto-oncogene involved in diverse neoplastic processes. Aberrant kinase activity of the KIT receptor has been targeted by tyrosine kinase inhibitor (TKI) therapy in different neoplasias. In all the earlier studies, KIT expression was reported to be absent in meningiomas. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Masum, Jha, Ajaya Nand, Abrari, Andleeb, Ali, Sher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443037/
https://www.ncbi.nlm.nih.gov/pubmed/22672386
http://dx.doi.org/10.1186/1471-2407-12-212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443037/
https://www.ncbi.nlm.nih.gov/pubmed/22672386
http://dx.doi.org/10.1186/1471-2407-12-212

Ejemplares similares